drugset / Trial / NCT02955134
The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis
Completed
468 enrolled
Wangjing Hospital, China Academy of Chinese Medical Sciences
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine · collabBeijing University of Chinese Medicine · collabChina-Japan Friendship Hospital · collabGansu Provincial Hospital · collabGuangdong Provincial Hospital of Traditional Chinese Medicine · collabHebei Hospital of Traditional Chinese Medicine · collabShaanxi Hospital of Traditional Chinese Medicine · collabShanghai University of Traditional Chinese Medicine · collabShanxi Province hospital Research Institute of Traditional Chinese Medicine · collabThe First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine · collabTianjin Academy of Traditional Chinese Medicine Affiliated Hospital · collabTianjin Nankai Hospital · collabXiyuan Hospital of China Academy of Chinese Medical Sciences · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate efficacy of Chinese medicine treatment for chronic atrophic gastritis. It is a multi-center, randomized, placebo-controlled trial.
Timeline
- Start
- 2018-03-12
- Primary completion
- 2021-05-01
- Completion
- 2021-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Qilianxiaopi Decoction | Traditional medicine (herbal / TCM) | 200 ml | — |
| Background | Compound Azimtamide | Unknown | — | — |
| Background | HYDROTALCITE ANHYDROUS | Small molecule | — | — |